Document is current
Any future updates will be listed below
-
Authors
Tang, Emily
Wiencke, John K.
Warrier, Gayathri
Hansen, Helen
McCoy, Lucie
Rice, Terri
Bracci, Paige M.
Wrensch, Margaret
Taylor, Jennie W.
Clarke, Jennifer L.
Koestler, Devin C.
Salas, Lucas A.
Christensen, Brock C.
Kelsey, Karl T.
Molinaro, Annette M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA52689, P50CA097257, R01CA126831, R01CA139020, R25CA112355, and R01CA207360, P30CA168524, P20GM103418, P20GM130423, R01CA216265, R01CA253976)
National Brain Tumor Foundation
The Lower Grade Glioma (loglio) Research Collective
Robert Magnin Newman Endowed Chair in Neuro-oncology
Stanley D. Lewis and Virginia S. Lewis Endowment
Congressionally Directed Medical Research Programs (W81XWH-20-1-0778)
National Institute of General Medical Sciences (P20 GM104416)
- License Information
-
More Information
Article History
Received: 2 June 2022
Accepted: 11 October 2022
First Online: 28 October 2022
Declarations
:
: Glioma studies were approved by the Institutional Review Board of the University of California, San Francisco, Human Research Protection Program in the Office of Ethics and Compliance under UCSF Federal wide Assurance 00000068. Informed consent was obtained from all study participants.
: Not applicable.
: JKW and KTK are co-founders of Cellintec, which had no role in the current study.
